What is happening with PBT2?, page-9

lwlinwei, We know that there will be an otitis study by Dr. Neville. To start a randomized study with an unregistered drug needs a lot of paper works. Most likely this is now in the process, and very possible has been already for some months before nothing of it was published. She will have a coordinative role in the study (IMO). She is a microbiologist, not an otologist who will examine the patients. I would predict that this study will be also a multicenter study. Money is needed and the right place to get it from is the antimicrobial-resistant fund, IMO.

All of this cannot be on the shoulders of Dr. Neville. UniQuest has also established the Queensland Emory Drug Discovery Initiative (QEDDI), a world-class small molecule drug discovery and development group, dedicated to translating academic biomedical research into drug candidates for partnering. If ever it has now wonderful possibility to demonstrate its skills and help De. Neville to start this needed a PBT2 otitis study.